horiz_black-text_full-color_RED_CAMPP_edited_edited.png
Abstract Linear Background

Our Mission

It is our mission to develop better treatments for the current Covid-19 pandemic, and to ensure that we are prepared for future viral pandemics. The Center for Antiviral Medicines & Pandemic Preparedness (CAMPP) will draw upon world class drug discovery infrastructure embedded in an academic setting, as well as a network of expert virologists, chemists, pharmacologists, structural and computational biologists, and significant prior investments in global health drug discovery, to generate a more substantial pool of antiviral lead series and candidate drugs with the potential to address the immediate threat of SARS-CoV-2 and provide antiviral drug candidates that might quickly pivot to address future outbreaks or pandemics caused by other viruses of pandemic concern, including other corona viruses, flavi viruses (yellow fever virus, dengue virus, Zika virus), paramyxo viruses, bunya viruses, toga viruses and filoviruses (such as Ebola virus).

Join us on our mission to build better treatments for the current pandemic,

and ensure we are prepared for the next one.

CAMPP is now recruiting for multiple positions!

AVIDD CAMPP Logos v2-01.png

Research Projects

The Center comprises six Projects that are supported by five Cores.

Project 1

Novel CoV Protease Inhibitors

Arnab Chatterjee | Calibr
Gaetano T. Montelione | Rensselaer Polytechnic Institute
Shaun Stauffer | Cleveland Clinic

Microscope
Image by Louis Reed

Project 2

Novel CoV Polymerase Inhibitors

Christopher F. Basler | Icahn School of Medicine at Mount Sinai
Gustavo Palacios | Icahn School of Medicine at Mount Sinai
Matthias Götte | University of Alberta
Christopher Parker | Scripps Research
Ben Cravatt | Scripps Research
Case McNamara | Calibr
Matthew Frieman | University of Maryland School of Medicine
Anil Gupta | Calibr

Project 3

Next-generation Antivirals Against
SARS-CoV-2 Druggable Proteins

Michael Farzan | UF Scripps Biomedical Research
Sumit Chanda | Scripps Research
Suganya Selvarajah | Prosetta Biosciences
John Guatelli | University of California San Diego
Stanley Opella | University of California San Diego
Stuart Lipton | Scripps Research
Hyeryun Choe | Scripps Research

Image by CDC
Image by CDC

Project 4

Antivirals Against Undruggable SARS-CoV-2 Targets

Adolfo García-Sastre | Icahn School of Medicine at Mount Sinai
Sumit Chanda | Scripps Research
Matthew D. Disney | UF Scripps Biomedical Research
Jose Gallego | Catholic University of Valencia
Hong Moulton | Oregon State University
Matthew J. Evans | Icahn School of Medicine at Mount Sinai
Beatriz Fontoura | UT Southwestern
Luis Martinez-Sobrido | Texas Biomedical Research Institute
Christopher Parker | Scripps Research
Ben Cravatt | Scripps Research

Project 5

Development of Antivirals to Flaviviruses

Sara Cherry | University of Pennsylvania
Sumit Chanda | Scripps Research
Michael S. Diamond | Washington University School of Medicine

Image by Егор Камелев
Image by CDC

Project 6

Development of Therapeutics
for Hemorrhagic Fever Viruses

Juan Carlos de la Torre | Scripps Research
Christopher F. Basler | Icahn School of Medicine at Mount Sinai
Jae Jung | Cleveland Clinic
Robert Davey | Boston University
Gaya Amarasinghe | Washington University School of Medicine
Christopher Parker | Scripps Research
Suganya Selvarajah | Prosetta Biosciences
Sumit Chanda | Scripps Research
Luis Martinez-Sobrido | Texas Biomedical Research Institute

Core A

High-throughput Screening Core

Kristen Johnson | Calibr

Pipetting Samples
Image by Chromatograph

Core B

Medicinal Chemistry Core

Anil Gupta | Calibr

Core C

Pharmacology & Formulation Core

Sean Joseph | Calibr
Victor Chi | Calibr

Scientist in the Lab
Image by Jaron Nix

Core D

Organoid & Animal Model Core

John Teijaro | Scripps Research
Matthew Frieman | University of Maryland School of Medicine
Jae Jung | Cleveland Clinic
Thomas Rogers | University of California San Diego
Kanta Subbarao | University of Melbourne

Core E

Structural Biology and Computational Modeling Core

Ian Wilson | Scripps Research
Andrew Ward | Scripps Research
Stefano Forli | Scripps Research

Image by Photoholgic
Petri Dish

Industry & Foundation Partners


Prosetta Biosciences
HitGen
Schrödinger
Johnson & Johnson
Intrepid Alliance
Gilead
Atomwise

Bill & Melinda Gates Foundation

Wellcome Trust